疾病
肝癌Liver cancer
肝癌 · ICD-10：C22 — Malignant neoplasm of liver and intrahepatic bile ducts
关键数据
仅为已发布的数值。每个图块都会打开带有其来源、年份与口径的章节。
疾病详情
- 规范中文名
- 肝癌
- 英文名
- Malignant neoplasm of liver and intrahepatic bile ducts
以中文写出的数值按来源原样引用。
又称
- 肝细胞癌（HCC）
- 原发性肝癌
- 肝恶性肿瘤
- Liver cancer
- HCC
治疗费用区间
以下每个区间都按一种计费口径发布：医保报销前。 来源未发布报销后数值，因此这里不展示。
| 治疗路径 | 费用区间 | 价格依据 | 数据年份 |
|---|---|---|---|
| 手术 | 未发布 | 未发布 | — |
| 放疗 | 19000 – 53000 CNY | 项目价 | 2025–2026 |
| 化疗 | 12000 – 49000 CNY | 全病程例均 | 2012–2014 |
| 靶向 | 28000 – 117000 CNY | 项目价 | 2025 |
| 免疫 | 32043 – 43803 CNY | 项目价 | 2024–2025 |
| 肝移植 | 300000 – 600000 CNY | 病种打包全包价 | 2018–2019 |
| 肝移植（活体／亲属供肝） | 未发布 | 未发布 | — |
上方的条形共用同一刻度：每条从该行已发布的下限值起，到其上限值止。本页最高的上限值为 600000 CNY。每行保留自己的数据年份与口径。
该疾病的 7 个费用区间，来源见各行页面。
以中文写出的数值按来源原样引用。
五年生存
5 年生存率 14.4% 95% 置信区间 14.2–14.5
- 人群
- 总体（全分期合并）· 年龄标准化相对生存率
- 时期
- 2019–2021
- 发布机构
- 国家癌症中心
- 数值性质
- 估计值（混合法）
- 登记范围
- 281 个肿瘤登记处
- 分期数据可用性
- 未按分期发布（来源仅发布总体数值）
以中文写出的数值按来源原样引用。
如何解读该数据。 它按全分期合并发布，因此是全国登记数据中所有人的平均值，而不是对某个人的预后。对多数癌症而言，确诊时的分期是生存差异背后最强的单一因素：通常，癌症发现得越早，生存率越高；发现得越晚，越低。不同癌症之间的比较也受到各自通常确诊早晚的影响，因此一个较低的数值本身并不意味着诊疗更差。
该数值是相对生存率：它把被诊断患此癌的人与一般人群中同年龄、同性别的人相比较，且为年龄标准化，因此它不是五年后仍存活患者所占的比例。它以估计值（混合分析）发布，因为登记报告存在滞后，故国家癌症中心对最近一段时期作了模型估计。作为参照，同一来源发布 2019–2021 年全部癌症合计的五年相对生存率为 43.7%。
在该疾病上有已发布记录的医院
依据官方公开数据来源筛选
这些医院依据官方公开数据来源筛选——复旦大学医院专科声誉排行榜、国家临床重点专科名单与国家临床医学研究中心——因此卡片上的每一行都可与其已发布的来源核对。这不是付费或推广位。
这些医院是如何筛选的
入选。当某疾病所归属的专科满足以下至少一项时，医院即被列入该疾病：在复旦大学医院专科声誉排行榜中有一个名次或提名；有一条 A、B 或 C 级的国家临床重点专科记录；或该专科有一个国家临床医学研究中心或国家重点实验室。JCI 认证仅作徽标展示；它绝不决定入选，也绝不决定排序。
排序。第 1 步：该专科在复旦榜中的第 1 至第 10 名。第 2 步：又一个复旦名次，或一个提名。第 3 步：一条 A 级国家临床重点专科。第 4 步：一条 B 级国家临床重点专科。第 5 步：该专科的一个国家临床医学研究中心或国家重点实验室，研究中心优先于实验室。第 6 步：一条 C 级国家临床重点专科——这是我们发布的一条没有独立官方来源的记录，因此排在其余之后。
平局。在同一步骤内：复旦名次更好的在前，其次重点专科等级更高者（A 先于 B，B 先于 C），再次省份，再次城市，最后医院名称——与医院目录所用的省—市—名称顺序相同。最多列出八家医院。
当名单较短时。五家及以上：列出前八家。三家或四家：全部列出，并有一个可展开的折叠区，把其余记录补至最多八条，每条都带其证据等级。一两家：同上，且该折叠区默认展开，并有一行说明有多少家医院有可靠的公开记录。没有：页面说明未找到可靠的公开记录，并链接到专科目录。绝不为了凑数而编造名次、机构或数量。
复旦排行榜是中国临床医生最广泛认可的医院专科声誉排行榜，由复旦大学医院管理研究所每年发布。
-
复旦大学附属肿瘤医院Fudan University Shanghai Cancer Center
国家临床重点专科
- Hepatobiliary Surgery（B 级） https://www.shca.org.cn/home/news/content/id/297/pid/25651
已发表研究
- Combination of programmed death protein-1 inhibitor improves the efficacy of transarterial chemoembolization plus lenvatinib for unresectable intermediate-stage hepatocellular carcinoma: a real-world multi-center retrospective study. European journal of radiology, 2026
- The conversion window in hepatocellular carcinoma: When resectability alone is not an indication for surgery. Drug discoveries & therapeutics, 2026
PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。
同时上榜：在复旦榜中为 Thoracic Surgery #10, Medical Oncology #3, 核医学 获提名。
-
中日友好医院China-Japan Friendship Hospital
国家临床重点专科
- Hepatobiliary Surgery（B 级） https://www.zryhyy.com.cn/zryh/c100020/202309/47e8245aa93343baac89762d4e80580f.shtml
已发表研究
- Toward the Era of Precision Immunotherapy: The Clinical Landscape and Future Directions of mRNA Vaccines for the Treatment of Hepatocellular Carcinoma. Journal of gastroenterology and hepatology, 2026
PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。
同时上榜：在复旦榜中为 Respiratory Medicine #2, Thoracic Surgery 获提名。
-
广东省人民医院Guangdong Provincial People's Hospital
国家临床重点专科
- Hepatobiliary Surgery（B 级） https://www.gdghospital.org.cn/NewsHospital/info_itemid_67669.html
已发表研究
- Mechanisms of Wu Zhuyu Decoction in the treatment of hepatocellular carcinoma: An integrative review of ethnopharmacology, pharmacological actions, and clinical potential. Journal of ethnopharmacology, 2026
- Integrating multiphase MRI radiomics of tumor and peritumoral regions to predict early progression in Hepatocellular Carcinoma: A multicenter study. European journal of radiology, 2026
PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。
-
江苏省人民医院（南京医科大学第一附属医院）Jiangsu Province Hospital
国家临床重点专科
- Hepatobiliary Surgery（B 级） https://www.jsph.org.cn/info/3031/71721.htm
同时上榜：在复旦榜中为 General Surgery 获提名, Otorhinolaryngology 获提名。
-
华中科技大学同济医学院附属同济医院Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
国家临床重点专科
- Hepatobiliary Surgery（B 级） https://www.tjh.com.cn/contents/934/27291.html
- Hepatobiliary Surgery（B 级） https://www.tjh.com.cn/contents/934/27291.html
同时上榜：在复旦榜中为 General Surgery #6, Urology #5, Gynecology #2。
-
湖南省人民医院Hunan Provincial People's Hospital
国家临床重点专科
- Hepatobiliary Surgery（B 级） http://www.hnsrmyy.com/index.php?catid=115
已发表研究
- Advances in galactose-based small-molecule hepatocyte-targeting probes for detecting biomarkers in hepatocellular carcinoma. Frontiers in chemistry, 2026
- AKR1B10 Drives Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing Ferroptosis via NQO1/GPX4 Axis. Journal of gastroenterology and hepatology, 2026
另有 5 项已发表研究
PubMed 收录了 7 篇关于该疾病、并提及这家医院的论文。
-
中国医科大学附属第一医院First Hospital of China Medical University
国家临床重点专科
- Hepatobiliary Surgery（B 级） https://www.cmu1h.com/features/specialty
已发表研究
- ZDHHC16-induced GPX2 S-palmitoylation promotes lenvatinib resistance and inhibits lenvatinib-induced immunogenic cell death in hepatocellular carcinoma. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2026
PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。
同时上榜：在复旦榜中为 核医学 #9, General Surgery 获提名, Urology 获提名。
临床试验（在研治疗）
除标准治疗外，针对 Liver cancer 的临床研究目前可能在中国开放招募受试者。在研治疗尚未获监管机构批准为标准疗法——它们是临床研究，而非常规治疗。每条记录都注明主要研究者与开展研究的医院。如有兴趣，请联系医院了解是否符合条件，并自行决定是否申请。
-
研究 Systemic Therapy Combined With Stereotactic Body Radiotherapy Versus Systemic Therapy Alone in BCLC Stage C Hepatocellular Carcinoma (SCRATCH): A Prospective, Multicenter, Phase II, Randomized Controlled Trial
- 主要研究者
- Jinbo Yue · Director of Department Radiation Oncology
- 医院
- Shandong Cancer Hospital
- 状态
- 招募中
- 登记库
- NCT07274774
-
研究 Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma After Radical Surgery With Donafenib in Combination With Envafolimab: a Prospective, Multicentre, Single-arm Phase II Clinical Study
- 医院
- Anhui Provincial Hospital
- 状态
- 招募中
- 登记库
- NCT06498622
-
研究 A Phase III, Randomized, Double-blinded, Multicenter Study of Cadonilimab (AK104) + Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
- 医院
- Henan Cancer Hospital
- 状态
- 招募中
- 登记库
- NCT06371157
-
研究 Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma: a Phase II, Single-arm, Prospective Study
- 医院
- Guangdong Provincial People's Hospital
- 状态
- 招募中
- 登记库
- NCT05954897
-
研究 Correlation Between Plasma Sphingolipid Metabolites and the Efficacy of Radiotherapy in Hepatocellular Carcinoma
- 医院
- Nanfang Hospital
- 状态
- 招募中
- 登记库
- NCT06864221
另有 58 项已登记研究
-
研究 A Prospective, Non-interventional Study of Different First-line Immunotherapy in Advanced Hepatocellular Carcinoma Patients: Efficacy and Immune Microenvironment Dynamics
- 主要研究者
- Peng Wang · professor
- 医院
- Zhongshan Hospital
- 状态
- 招募中
- 登记库
- NCT07147101
-
研究 Clinical Study of Glypican-3 (GPC3)-Targeted Novel Probe 18F-X12 for the Diagnosis of Hepatocellular Carcinoma (HCC)
- 主要研究者
- Meng LIU · Chief Physician
- 医院
- Peking University First Hospital
- 状态
- 招募中
- 登记库
- NCT07795437
-
研究 Integrative Multimodal Imaging and Multi-omics Profiling of HCC Heterogeneity: a Translational Exploratory Study Leveraging CEUS, Elastography, SMI, PAI, Multi-omics Analysis, and AI-driven Modeling to Advance Precision Diagnosis and Therapeutic Optimization
- 医院
- Peking Union Medical College Hospital
- 状态
- 招募中
- 登记库
- NCT07101237
-
研究 Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma
- 医院
- Nanfang Hospital
- 状态
- 招募中
- 登记库
- NCT06623474
-
研究 An Exploratory Clinical Study on the Safety and Efficacy of Autologous Chimeric Antigen Receptor T Cells Targeting Glypican-3 (CG-102-12C) in the Treament of Advanced Hepatocellular Carcinoma
- 主要研究者
- TingBo Liang · Director physician
- 医院
- The First Affiliated Hospital, Zhejiang University School of Medicine
- 状态
- 招募中
- 登记库
- NCT07039201
-
研究 Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma: A Prospective, Exploratory, Single-Arm Study (CLEAR-2)
- 医院
- Huashan Hospital
- 状态
- 招募中
- 登记库
- NCT07331883
-
研究 Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Multicenter, Prospective, Phase II Study
- 主要研究者
- Zhou Qunfang · Clinical Professor
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT06550921
-
研究 Hepatic Arterial Infusion Chemotherapy Compared With Transcatheter Arterial Chemoembolizationin Intermediate-advanced Huge Hepatocellular Carcinoma: a Multicenter Retrospective Study
- 主要研究者
- Zhou Qunfang · Clinical Professor
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT06641713
-
研究 Efficacy of HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma: an Observational, Real-world Study
- 主要研究者
- Zhou Qunfang · Clinical Professor
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT06333561
-
研究 Phase II Study of Neoadjuvant CT-Guided Intra-tumor Double Checkpoint Blockades for Untreated Hepatocellular Carcinoma (HCC) Amenable for Surgical Resection
- 医院
- The Second Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06492408
-
研究 A Multi-center, Randomized, Controlled, Open-label Phase II/III Clinical Trial to Investigate Whether Transarterial Tirapazamine Injection Followed by Transarterial Embolization (TATE) is Superior to Traditional Transarterial Chemoembolization (TACE) in Patients With Intermediate-Stage Hepatocellular Carcinoma (HCC)
- 医院
- Zhongda Hospital Southeast University
- 状态
- 招募中
- 登记库
- NCT06844357
-
研究 Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer
- 医院
- Anhui Provincial Hospital
- 状态
- 招募中
- 登记库
- NCT07356531
-
研究 An Open-Label, Multicenter, Phase I/II Study Evaluating MRG006A in Combination With Immune Checkpoint Inhibitors and Targeted Therapy in Patients With Advanced Hepatocellular Carcinoma
- 医院
- Beijing Youan Hospital, Capital Medical University
- 状态
- 招募中
- 登记库
- NCT07479485
-
研究 A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (SIRT) Therapy and Hepatic Arterial Infusion Chemotherapy (HAIC) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma
- 主要研究者
- Li Qiang · Chief Physician of Hepatobiliary Surgery
- 医院
- The First Affiliated Hospital of Jinan University
- 状态
- 招募中
- 登记库
- NCT07070076
-
研究 A Phase 2, Single-Arm Study of Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy
- 主要研究者
- Xu Yong, MD · Secretary of the Party Committee & Principal Investigator
- 医院
- Shenzhen Third People's Hospital
- 状态
- 招募中
- 登记库
- NCT06563947
-
研究 Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma
- 主要研究者
- Jianbo Chen · director
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT05970666
-
研究 An Early Clinical Study to Evaluate the Safety and Efficacy of SN301A Cell Injection in the Treatment of Subjects with Glypican-3 (GPC3)-Positive Advanced Hepatocellular Carcinoma
- 主要研究者
- Qi Li · Head of Oncology
- 医院
- Shanghai General Hospital
- 状态
- 招募中
- 登记库
- NCT06652243
-
研究 Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring Minimal Residual Disease Based on Circulating Tumor DNA
- 医院
- Zhujiang Hospital of Southern Medical University
- 状态
- 招募中
- 登记库
- NCT06157060
-
研究 A Randomized Controlled Trial Evaluating Different Doses of Oral Zinc Supplementation in Combination With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07793695
-
研究 Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3
- 医院
- Beijing Hospital
- 状态
- 招募中
- 登记库
- NCT05738980
-
研究 A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study of Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection in Patients With High Risk of Relapse After Radical Surgery or Ablation of Hepatocellular Carcinoma (HCC).
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT05862337
-
研究 China Metastatic Liver Cancer Clinical Registry Cohort Database
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07602504
-
研究 A Multicenter, Open-label, Single-Arm Phase I/II Clinical Study to Evaluate the Safety and Efficacy of a Single Dose of MDN-001 Injection in Patients With Unresectable Primary Hepatocellular Carcinoma (HCC).
- 医院
- Anhui Provincial Hospital
- 状态
- 招募中
- 登记库
- NCT07391839
-
研究 The Performance of Spectral CT in Evaluating Treatment Response After Transarterial Chemoembolization for Hepatocellular Carcinoma: The SpecTRAIL Study
- 主要研究者
- Yuan-Cheng Wang · Head of Radiology
- 医院
- Zhongda Hospital Southeast University
- 状态
- 招募中
- 登记库
- NCT07351669
-
研究 China Liver Cancer Clinical Registry Cohort Database (HEAL)
- 医院
- Hefei First People's Hospital
- 状态
- 招募中
- 登记库
- NCT06777485
-
研究 Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation
- 主要研究者
- Beicheng Sun · Director, Hepatobiliary Surgery
- 医院
- Nanjing Drum Tower Hospital
- 状态
- 招募中
- 登记库
- NCT04595864
-
研究 Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
- 医院
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- 状态
- 招募中
- 登记库
- NCT06383520
-
研究 Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
- 医院
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- 状态
- 招募中
- 登记库
- NCT07059936
-
研究 Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomics-Liver）
- 医院
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- 状态
- 招募中
- 登记库
- NCT06536998
-
研究 Clinical Study to Evaluate the Safety and Efficacy of Personalized Tumor Neoantigen mRNA Therapy Combined With PD-1 Monoclonal Antibody and TACE for Advanced Hepatocellular Carcinoma
- 主要研究者
- TingBo Liang · The chairman of the First Affiliated Hospital of Zhejiang University School of Medicine
- 医院
- The First Affiliated Hospital, Zhejiang University School of Medicine
- 状态
- 招募中
- 登记库
- NCT06995105
-
研究 A Dose Ascending, Open Phase I Clinical Study to Evaluate the Safety, Tolerability , Pharmacokinetics Characteristics and Preliminary Effectiveness of VG161 in Subjects with Advanced Primary Liver Cancer
- 医院
- The First Affiliated Hospital, Zhejiang University School of Medicine
- 状态
- 招募中
- 登记库
- NCT04806464
-
研究 Neoadjuvant TACE Plus Iparomlimab and Tuvonralimab （QL1706）and Adjuvant QL1706 in Resectable BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria: the TITAN-HCC Phase II Trial
- 主要研究者
- Lunxiu Qin · Professor
- 医院
- Huashan Hospital
- 状态
- 招募中
- 登记库
- NCT07268131
-
研究 Exploration of A Holistic Management Procedure for Liver Cancer Surveillance in Improving Liver Cancer's Early Diagnosis Efficacy in Chinese Population: Single-Center, Prospective, Observational Real-world Study in EASTERN China
- 主要研究者
- Qing XIe · Director of Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
- 医院
- Ruijin Hospital
- 状态
- 招募中
- 登记库
- NCT05870969
-
研究 Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib and Tislelizumab for Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus: A Prospective, Multicenter, Single-arm Study
- 主要研究者
- Kai Li · Professor
- 医院
- First Hospital of China Medical University
- 状态
- 招募中
- 登记库
- NCT07483359
-
研究 Ablation of Pulmonary Oligometastasis Combined With System Compared System Therapy for Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study
- 主要研究者
- Zhou Qunfang · Clinical Professor
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT06644430
-
研究 Combination Therapy of Microwave Ablation and Expanding Activated Autologous Lymphocytes for Hepatocellular Carcinoma
- 主要研究者
- Ping Liang · Professor
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT02851784
-
研究 Surgical Resection Versus Maintenance Therapy for Hepatocellular Carcinoma Patients Achieving Complete Radiologic Response After Antitumor Therapy: A Randomized Controlled Exploratory Study
- 主要研究者
- Kunlin Xie · A/Prof
- 医院
- Peking Union Medical College Hospital
- 状态
- 尚未招募
- 登记库
- NCT07866612
-
研究 A Comparative Study on the Diagnostic Efficacy of Ultrasound Contrast LI-RADS Grading and the German ESCULAP Standards for the Diagnosis of Recurrent Hepatic Mass Lesions After Hepatocellular Carcinoma Surgery
- 主要研究者
- Dezhi Zhang · Principal Investigator ,PI
- 医院
- The First Hospital of Jilin University
- 状态
- 尚未招募
- 登记库
- NCT07600346
-
研究 Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation, Tumor-puncture Microwave Ablation and Surgical Resection for Subcapsular Hepatocellular Carcinoma
- 主要研究者
- Dezhi Zhang · Principal investiogator,PI
- 医院
- The First Hospital of Jilin University
- 状态
- 尚未招募
- 登记库
- NCT07748481
-
研究 A Phase III, Randomized, Double-blind, Multicenter Study of SHR-8068 and Adebrelimab Plus Bevacizumab in Combination With TACE in Participants With Incurable Hepatocellular Carcinoma
- 医院
- Zhongda Hospital Southeast University
- 状态
- 尚未招募
- 登记库
- NCT07691762
-
研究 Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases (CAPLocal) : A Multicentre, Single-Arm,Prospective Cohort Study
- 医院
- Xiangya Hospital of Central South University
- 状态
- 尚未招募
- 登记库
- NCT07482670
-
研究 Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma
- 医院
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- 状态
- 尚未招募
- 登记库
- NCT07352345
-
研究 A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion
- 主要研究者
- Zhai Wenlong · Porfessor
- 医院
- First Affiliated Hospital of Zhengzhou University
- 状态
- 尚未招募
- 登记库
- NCT07790419
-
研究 Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular Carcinoma
- 主要研究者
- Ping Liang · M.D.
- 医院
- Chinese PLA General Hospital
- 状态
- 尚未招募
- 登记库
- NCT06798194
-
研究 A Prospective Phase II Study of Fatty Acid Degradation (FAD) Subtype-Guided Comprehensive Therapy for Unresectable Hepatocellular Carcinoma
- 主要研究者
- YU DE CAI · Professor
- 医院
- Nanjing Drum Tower Hospital
- 状态
- 尚未招募
- 登记库
- NCT07314372
-
研究 A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular Carcinoma
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 尚未招募
- 登记库
- NCT06779461
-
研究 A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation
- 主要研究者
- lucaide · Chief Physician/Professor
- 医院
- Ningbo Medical Center Lihuili Hospital
- 状态
- 尚未招募
- 登记库
- NCT07310836
-
研究 A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma
- 主要研究者
- Caide Lu · Chief Physician
- 医院
- Ningbo Medical Center Lihuili Hospital
- 状态
- 尚未招募
- 登记库
- NCT07368023
-
研究 A Non-randomized Controlled, Prospective, Real-world Study to Evaluate the Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
- 主要研究者
- Liyun Fu · Chief Physician
- 医院
- Ningbo Medical Center Lihuili Hospital
- 状态
- 尚未招募
- 登记库
- NCT07553767
-
研究 The Impact of Different Antiviral Strategies on Tumor Prognosis in Patients With HBV-related Liver Cancer After Radical Treatment: A Prospective, Open-label, Non-randomized Clinical Study
- 医院
- Shenzhen Third People's Hospital
- 状态
- 尚未招募
- 登记库
- NCT07120750
-
研究 Compare the Accuracy of Circulating Tumor DNA Longitudinal Monitoring Minimal Residual Disease and Microvascular Invasion Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma
- 医院
- Zhujiang Hospital of Southern Medical University
- 状态
- 尚未招募
- 登记库
- NCT06449846
-
研究 The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus Transarterial Chemoembolization (TACE) or Hepatic Arterial Infusion Chemotherapy (HAIC) as First-line Treatment for Unresectable Hepatocellular carcinomaA Multicenter, Retrospective Clinical Study
- 医院
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University
- 状态
- 尚未招募
- 登记库
- NCT07724951
-
研究 Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study
- 主要研究者
- Gu Jinyang · Director of Hepatobiliary and Pancreatic Surgery Department
- 医院
- The First Affiliated Hospital of Chongqing Medical University
- 状态
- 尚未招募
- 登记库
- NCT07324473
-
研究 Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study
- 医院
- Nanfang Hospital
- 状态
- 尚未招募
- 登记库
- NCT07544121
-
研究 Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy:A Single-Arm, Multicenter Clinical Study
- 医院
- Nanfang Hospital
- 状态
- 尚未招募
- 登记库
- NCT07537777
-
研究 Identification of a Novel 29-Gene-Based Subtype of Hepatocellular Carcinoma and Its Correlation With Immunotherapy Efficacy
- 主要研究者
- Junjie Xu · Associate Chief Physician
- 医院
- Anhui Provincial Hospital
- 状态
- 尚未招募
- 登记库
- NCT07100236
-
研究 A Real-World Study on Reducing the Risk of Liver Cancer in Chronic Hepatitis B Patients With a Family History of HBV-Related Liver Cancer.
- 主要研究者
- Guiqiang Wang · Chief physician
- 医院
- Second Affiliated Hospital of Harbin Medical University
- 状态
- 尚未招募
- 登记库
- NCT07007286
-
研究 Phase I/II Study of CAR-T Cell Therapy Targeting GPC3 in Patients with Treated Advanced GPC3-Positive Hepatocellular Carcinoma
- 主要研究者
- Han weidong · Director of the Department of Biotherapeutics
- 医院
- Chinese PLA General Hospital
- 状态
- 尚未招募
- 登记库
- NCT06641453
本页仅分享公开登记的研究信息，不推荐也不鼓励参加任何研究。参加完全自愿，且未经批准治疗的风险尚不明确；请直接联系医院了解入组条件与知情同意细节。
拥有国家临床重点专科记录的医院
显示医院记录 7 家拥有重点专科记录的医院
每一行都是在某疾病所归属专科中拥有国家临床重点专科记录的医院。这是对已发布名单的记录，既不构成推荐，也不是排名。
7 家拥有匹配的国家临床重点专科记录的医院。
以中文写出的数值按来源原样引用。
患者报告的情况
仅为汇总数据：一项全国性结果，附其来源与所指年份。这不是患者证言，也不是关于某一个人的陈述。
据 National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号)（2023）报道：National inpatient satisfaction / outpatient satisfaction — 95.42 / 93.95 score, 0-100。
National aggregate across the 2,168 tertiary public hospitals that took part in the national performance monitoring (all conditions combined; not disease-specific, not hospital-specific).
来源：National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号) — https://www.gov.cn/zhengce/zhengceku/202503/content_7016208.htm — 2023 — A 级
关于该疾病的问题
我们不能提供医疗建议，但可以回答关于本页以及在中国安排就医的问题。
ICD 编码
显示编码表 8 个 ICD 编码
| 版本 | 编码 | 该版本中的名称 |
|---|---|---|
| ICD-10-WHO | C22 | Malignant neoplasm of liver and intrahepatic bile ducts |
| ICD-10-WHO | C22.0 | Liver cell carcinoma |
| ICD-10-WHO | C22.1 | Intrahepatic bile duct carcinoma |
| ICD-10-WHO | C22.2 | Hepatoblastoma |
| ICD-10-WHO | C22.3 | Angiosarcoma of liver |
| ICD-10-WHO | C22.4 | Other sarcomas of liver |
| ICD-10-WHO | C22.7 | Other specified carcinomas of liver |
| ICD-10-WHO | C22.9 | Liver, unspecified |
各行为该疾病的 WHO ICD-10 条目，按原样引用。
来源与证据
- 来源 URL
- https://wjw.fujian.gov.cn/xxgk/fgwj/zxwj/201904/P020190412506737868905.xlsx
- 来源协议
- https
- 来源类型
- 省级卫生健康委员会
- 证据等级
- A ——由卫生健康委员会、国家级研究机构或大学所述
- 获取日期
- 2026-09-24